Seelos Therapeutics Shares Are Trading Lower After the Company Announced That Its ALS Study With SLS-005 Did Not Meet Statistical Significance in the Primary and Secondary Endpoint in the Full Analysis Set
Seelos Therapeutics 宣佈其針對 SLS-005 的 ALS 研究在完整分析集中的主要和次要終點未達到統計學意義後,該公司股價走低